Ozempic, Wegovy and Zepbound get new FDA warning over rare condition
The FDA is requiring new warnings for GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound over a potential increased risk of a rare eye condition that can cause permanent vision loss.
Original Source
Read the full article at Al →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.